The Kansas State Senate made a bold move to make early COVID-19 treatments more accessible for the general population.
In a letter addressed to healthcare providers, the Kansas Senate Chamber laid out clear directives for treatment protocols.
The failure to utilize all FDA-approved medications, regardless of their labeled uses, will now be considered “wanton disregard.”
The “Off-Label Drug Bill” would allow healthcare providers to prescribe and dispense off-label drugs for COVID-19 treatment, including ivermectin and hydroxychloroquine.
The Kansas State Senate followed up their vote with the aforementioned letter penned to healthcare providers.
Here’s a snapshot:
Richard – I am shocked. This is incredible, like a damn breaking (or a crack forming). Big move by Kansas. Someone gets it. A lot of people get it. But many don't. Kansas and Florida leading the way to early treatment. People are coming around to the Truth. Finally. https://t.co/cmMQGKNfhE
— Pierre Kory, MD MPA (@PierreKory) April 5, 2022
ALL STATES NEED TO JOIN KANSAS IN DEMANDING ACCESS TO EARLY TREATMENT OPTIONS FOR COVID! THIS SHOULD HAVE BEEN DONE TWO YEARS AGO WITH THOUSANDS OF UNNECESSARY DEATHS! WE DEMAND ANSWERS!!!! pic.twitter.com/XssPcAjsEY
— Renaissance Dudes (@RenaissanceDud2) April 2, 2022
#Kansas Mandated treatment #covid Finally a State willing to treat anyway they can. #medicine the right way. @Covid19Critical @FrontlineFlash @JMichaelWaller @mmasonesq @LABeachGal1 Pass to all! pic.twitter.com/RElUnnuOuy
— Absolute Civ Security 🇺🇸 🌸 (@_ACSCOOLGROUP) April 5, 2022
In other countries, like El Salvador, it’s incredibly easy to get your hands on medications like ivermectin.
The Kansas State Senate is among the leaders in helping American citizens gain the same ease of accessibility to affordable treatments.
However, there remains resistance in the Kansas House of Representatives.
The Topeka-Capital Journal explained:
The Legislature didn’t act on four pandemic-inspired bills rewriting public health laws: SB 489, SB 541, HB 2280 and HB 2416. The Senate previously passed the bills, but the House hasn’t been receptive to taking up the issues.
The legislation to promote ivermectin and hydroxychloroquine as off-label drugs to treat COVID-19 has been the most controversial of the four public health bills. Hilderbrand tried to push for that bill, HB 2280, during a Friday evening health conference committee meeting. Rep. Brenda Landwehr, R-Wichita, said no.
“I thought we had settled on some potential new language, and then discovered yesterday that we had not,” Landwehr said. “At this stage that we’re at, we’re not willing to move on that with what you’re offering.”
Kansas legislators have gone home for a spring break and unresolved issues will be taken up during the veto session, which starts April 25th.